The albumin-bilirubin (ALBI) model in hepatocellular carcinoma (HCC) may better predict hepatic failure in patients with traditionally low-risk cirrhosis following definitive stereotactic body radiotherapy (SBRT)

[1]  V. Kudithipudi,et al.  Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy , 2017, World journal of gastrointestinal surgery.

[2]  V. Kudithipudi,et al.  Liver stereotactic radiotherapy (SRT) with functional treatment planning for patients with intermediate stage hepatocellular carcinoma (HCC) , 2017, Journal of Radiation Oncology.

[3]  A. Koong,et al.  Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer. , 2017, Practical radiation oncology.

[4]  V. Mazzaferro,et al.  Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma. , 2016, JAMA surgery.

[5]  H. Toyoda,et al.  Usefulness of albumin–bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma , 2016, Journal of gastroenterology and hepatology.

[6]  V. Kudithipudi,et al.  Stereotactic body radiotherapy (SBRT) with or without surgery for primary and metastatic liver tumors. , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[7]  Cynthia S. Johnson,et al.  Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy. , 2015, Practical radiation oncology.

[8]  B. Sangro,et al.  Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  H. El‐Serag,et al.  Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go? , 2014, Hepatology.

[10]  Zahra Kassam,et al.  Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  O. Gayou,et al.  A method for registration of single photon emission computed tomography (SPECT) and computed tomography (CT) images for liver stereotactic radiotherapy (SRT). , 2012, Medical physics.

[12]  J. West,et al.  All‐cause mortality in people with cirrhosis compared with the general population: a population‐based cohort study , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[13]  A. Koong,et al.  Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. , 2010, International journal of radiation oncology, biology, physics.

[14]  S. Perkins,et al.  Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma , 2010, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[15]  L. Gaspar,et al.  Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Maria Hawkins,et al.  Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Xiao-dong Zhu,et al.  Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma. , 2006, International journal of radiation oncology, biology, physics.

[18]  Peter C Levendag,et al.  Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study , 2006, Acta oncologica.

[19]  W. Franklin,et al.  Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  G. D’Amico,et al.  Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. , 2006, Journal of hepatology.

[21]  J. Bruix,et al.  Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.

[22]  C. G. Child.  [REMOTE RESULTS OF PORTAL SURGERY IN LIVER CIRRHOSIS]. , 1964, Revue internationale d'hepatologie.

[23]  Child Cg.  REMOTE RESULTS OF PORTAL SURGERY IN LIVER CIRRHOSIS , 1964 .